Elevated osteopontin levels in active relapsing-remitting multiple sclerosis

被引:97
|
作者
Vogt, MHJ
Lopatinskaya, L
Smits, M
Polman, CH
Nagelkerken, L
机构
[1] TNO Prevent & Hlth, Div Infect Dis & Immunol, NL-2301 CE Leiden, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands
关键词
D O I
10.1002/ana.10606
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In the search for proteins that might play a role in the pathogenesis of multiple sclerosis (MS), osteopontin (OPN) has been identified as the most prominent cytokine-encoding gene expressed within MS lesions. Here, we report significantly increased OPN protein levels in plasma of relapsing-remitting MS patients. In contrast, OPN protein levels in primary progressive and secondary progressive MS patients were similar to healthy control levels. Interestingly, active relapsing-remitting patients had higher OPN protein levels than patients without relapses.
引用
收藏
页码:819 / 822
页数:4
相关论文
共 50 条
  • [1] Elevated osteopontin levels precede increased disease activity in relapsing-remitting multiple sclerosis
    Vogt, MHJ
    Floris, S
    Killestein, J
    Smits, M
    Barkhof, F
    Polman, CH
    Nagelkerken, A
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 100 - 100
  • [2] Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients
    Vogt, MHJ
    Floris, S
    Killestein, J
    Knol, DL
    Smits, M
    Barkhof, F
    Polman, CH
    Nagelkerken, L
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2004, 155 (1-2) : 155 - 160
  • [3] Osteopontin plasma levels in relapsing remitting multiple sclerosis
    Allahdadian, S.
    Etemadifar, M.
    Alsahebfosul, F.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 785 - 785
  • [4] Relapsing-remitting multiple sclerosis
    Flores, A
    Ochoa, E
    Zamora, S
    Barrientos, UN
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 110 - 110
  • [5] Serum amyloid A protein is elevated in relapsing-remitting multiple sclerosis
    Ristori, G
    Laurenti, F
    Stacchini, P
    Gasperini, C
    Buttinelli, C
    Pozzilli, C
    Salvetti, M
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1998, 88 (1-2) : 9 - 12
  • [6] Osteopontin plasma levels in relapsing-remitting multiple sclerosis patients are related to bone-specific markers
    Vogt, M. H. J.
    Heijnen, D. A. M.
    Iacobaeus, E.
    Teunissen, C. E.
    Brundin, L.
    Nagelkerken, L.
    Polman, C.
    Dijkstra, C. D.
    [J]. MULTIPLE SCLEROSIS, 2007, 13 : S155 - S155
  • [7] Alemtuzumab: A new therapy for active relapsing-remitting multiple sclerosis
    Hartung, Hans-Peter
    Aktas, Orhan
    Boyko, Alexey N.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (01) : 22 - 34
  • [8] Highlights on cyclophosphamide effect in active relapsing-remitting multiple sclerosis
    Zakaria, Magd Fouad
    Swelam, Mahmoud Saad
    Zamzam, Dina AbdEl-Gawad
    Nasef, Ayman Mohamed
    Helal, Samia Ashor
    Hafeez, Mohamed Aly Abdel
    Abou Steit, Alaa Mohamed
    Khater, Shaimaa Sayed
    Fouad, Mohamad Mahmoud
    Hady, Ayman Abdel
    Attia, Mohamed Hamdi
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP27 - NP28
  • [9] Autohemotherapy for relapsing-remitting multiple sclerosis
    Mubaidin, AF
    Horani, KA
    Dehayyat, MA
    Shehab, M
    Abu-Ruman, IA
    Shurbaji, AA
    Kurdi, A
    Hiari, M
    Khakish, M
    Harahsheh, O
    Dabbas, M
    [J]. NEUROLOGY, 2001, 56 (08) : A75 - A75
  • [10] Relapsing-remitting tumefactive multiple sclerosis
    Selkirk, SM
    Shi, J
    [J]. MULTIPLE SCLEROSIS, 2005, 11 (06): : 731 - 734